BMC Pulmonary Medicine · 2024 · 11 citations · 34 references
MedicineInternal MedicineClinical EpidemiologyEpidemiologyPulmonologyChronic Obstructive Pulmonary DiseaseRespiratory DiseaseAcute Exacerbation TreatmentChronic Obstructive Pulmonary Disease DisparitiesChronic Obstructive Pulmonary Disease EpidemiologyChronic Obstructive Pulmonary Disease Exacerbation TreatmentIn-hospital MortalityLong-term Clinical SuccessPulmonary ExacerbationsSex Differences In Morbidity
BACKGROUND: Data related to the characteristics, treatments and clinical outcomes of acute exacerbation of chronic obstructive pulmonary disease (AECOPD) patients in China are limited, and sex differences are still a neglected topic. METHODS: The patients hospitalized for AECOPD were prospectively enrolled from ten medical centers in China between September 2017 and July 2021. Patients from some centers received follow-up for 3 years. Data regarding the characteristics, treatments and in-hospital and long-term clinical outcomes from male and female AECOPD patients included in the cohort were analyzed and compared. RESULTS: In total, 14,007 patients with AECOPD were included in the study, and 11,020 (78.7%) were males. Compared with males, female patients were older (74.02 ± 10.79 vs. 71.86 ± 10.23 years, P < 0.001), and had more comorbidities (2.22 ± 1.64 vs. 1.73 ± 1.56, P < 0.001), a higher frequency of altered mental status (5.0% vs. 2.9%, P < 0.001), lower diastolic blood pressure (78.04 ± 12.96 vs. 79.04 ± 12.47 mmHg, P < 0.001). In addition, there were also significant sex differences in a range of laboratory and radiographic findings. Females were more likely to receive antibiotics, high levels of respiratory support and ICU admission than males. The in-hospital and 3-year mortality were not significantly different between males and females (1.4% vs. 1.5%, P = 0.711; 35.3% vs. 31.4%, P = 0.058), while female smokers with AECOPD had higher in-hospital mortality than male smokers (3.3% vs. 1.2%, P = 0.002) and male smokers exhibited a trend toward higher 3-year mortality compared to female smokers (40.7% vs. 33.1%, P = 0.146). CONCLUSIONS: In AECOPD inpatients, females and males had similar in-hospital and long-term survival despite some sex differences in clinical characteristics and treatments, but female smokers had significantly worse in-hospital outcomes than male smokers. CLINICAL TRIAL REGISTRATION: Retrospectively registered, registration number is ChiCTR2100044625, date of registration 21/03/2021. URL: http://www.chictr.org.cn/showproj.aspx?proj=121626 .
34
Gregory A. Roth, Degu Abate, Kalkidan Hassen Abate et al. · The Lancet · 2018 · 8.7K citations · Full text
Public Health, Health Sciences, Population Health Sciences +17
Characterisation of COPD heterogeneity in the ECLIPSE cohort
Àlvar Agustí, Peter M.A. Calverley, Bartolomé R. Celli et al. · Respiratory Research · 2010 · 1.2K citations · Full text